CCL22 and neoplasm: TAMs interact intensively with tumor and lymphoid cells, expressing high levels of CCL2, CCL18, and CCL22 to recruit suppressive Tregs, while PD-L1 and IDO1 expression directly inhibits T cells effector function (91).